Matt S. Anderson

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

24

H-Index

1

About

Matt S. Anderson has made significant contributions to the field of lipid metabolism and enzyme biochemistry, with a particular focus on endothelial lipase (EL)—a key regulator of high-density lipoprotein (HDL) cholesterol levels. His most cited work, "Fluorogenic substrates for high-throughput measurements of endothelial lipase activity" (2006, 24 citations), introduced innovative fluorescent Bodipy-based substrates that enabled rapid, sensitive, and scalable assays for EL activity. This breakthrough was instrumental in advancing the discovery of small molecule inhibitors specifically targeting EL, offering a potential therapeutic avenue for modulating HDL cholesterol and addressing cardiovascular disease risk. Anderson’s research bridges the gap between fundamental enzymology and drug discovery, providing tools that have been widely adopted in both academic and pharmaceutical settings. His work underscores the importance of developing precise, high-throughput methodologies to unravel complex lipid regulatory pathways. By creating accessible assays for EL activity, Anderson has empowered researchers to explore new interventions for dyslipidemia, cementing his impact on the study of lipoprotein metabolism and cardiovascular health.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Fluorogenic substrates for high-throughput measurements of endothelial lipase activity
24 citations · 2006
📈 Most Prolific Year: 2006 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago